27.08.2021 • News

Egypt Plans $1.6 Billion Methanol/Ammonia Project

Helwan Fertilizers, Abu Qir Fertilizers and Al Ahly Capital Holding have agreed to set up a new company for producing methanol, ammonia and petrochemicals.

According to a statement by the Egyptian Cabinet, the new company will aim to meet local market demand for methanol and its derivatives, while exporting any surplus overseas.

Abu Qir Fertilizers and Helwan Fertilizers will each take a 35% stake in the company, while Al Ahly Capital Holding will own the remaining 30% share.

The first phase of the project will see $1.6 billion invested to build plants in the economic zone of the Suez Canal in Ain Sokhna, Egypt, for producing an estimated 1 million t/y methanol and 400,000 t/y ammonia.

Chairman of Abu Qir Fertilizer Saad Abu Al-Maaty said the project will be built in two stages and that all the necessary approvals for allocating land and securing natural gas feedstock have been obtained.

The partners added that a study has already confirmed the project’s economic and market feasibility.

Author: Elaine Burridge, Freelance Journalist

Helway Fertilizers, Abu Qir Fertilizers and Al Ahly Capital Holding will form a...
Helway Fertilizers, Abu Qir Fertilizers and Al Ahly Capital Holding will form a new company that will invest $1.6 billion to build plants in the economic zone of the Suez Canal in Ain Sokhna, Egypt, for producing an estimated 1 million t/y methanol and 400,000 t/y ammonia. (c) Pixabay

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read